https://www.lupus.org/news/fda-grants-fast-track-status-to-investigational-therapy-impt514-for-treatment-of-both-active
Fast Track designation by the FDA is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an...
fast track statusinvestigational therapyfdagrantsimpt
https://www.lupus.org/news/first-person-dosed-with-investigational-therapy-adi001-for-treatment-of-lupus-nephritis
This study aims to evaluate the safety and tolerability of ADI-001, with preliminary data expected in 2025.
first personinvestigational therapydosedaditreatment
https://www.prnewswire.com/news-releases/merck-kgaa-darmstadt-germany-presents-updated-results-for-investigational-therapy-tepotinib-demonstrating-durable-clinical-response-in-patients-with-advanced-nsclc-with-metex14-skipping-mutations-300860623.html
/PRNewswire/ -- Alterations of the MET signaling pathway are present in 3-5% of non-small cell lung cancer patients and correlate with poor prognosis New...
merck kgaaupdated resultsinvestigational therapydarmstadtgermany
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01179
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With...
experimental medicationimmunotherapystudybms
https://www.technologynetworks.com/drug-discovery/news/abbvie-and-alvine-to-collaborate-on-investigational-oral-therapy-for-celiac-disease-184707
AbbVie secures exclusive option to acquire global rights to ALV003.
oral therapyabbviecollaborate